Clinical review report: Etonogestrel extended-release subdermal implant (Nexplanon) Merck Canada Inc. : indication: for the prevention of pregnancy
The objective of this report was to perform a systematic review of the beneficial and harmful effects of radiopaque etonogestrel extended-release subdermal implant 68 mg (Nexplanon) for the prevention of pregnancy in women
Corporate Author: | |
---|---|
Format: | eBook |
Language: | English |
Published: |
Ottawa (ON)
Canadian Agency for Drugs and Technologies in Health
2020, December 2020
|
Edition: | Version: Final |
Series: | CADTH common drug review
|
Online Access: | |
Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Table of Contents:
- Includes bibliographical references